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Abstract 
 
Doxorubicin is a commonly used chemotherapeutic agent in patients with breast 
cancer. The risk of side effect using of doxorubicin  such as cardiomyopathy and congestive 
heart failure which can lead to death. One of the  approach to overcome overloaded use of 
doxorubicin is the combined use with a chemopreventive agent (cochemotherapy), including 
the leaf extract of marigolds (Cosmos caudatus Kunth.). This research aims to reviewing the 
effect of the methanol extract of leaves of marigolds on the cytotoxic activity of doxorubicin 
in modulating cell cycle and apoptosis of breast cancer cells T47D. Determination of the 
cytotoxic activity of methanol extract of leaves of marigolds and doxorubicin as well as a 
combination of both conducted by MTT assay. modulation surveillance of cell cycle and 
apoptosis induction is done by using flowcytometry and analyzed by FACS Calibur program. 
Cytotoxicity assay single treatment of the methanol extract of leaves of marigolds produce 
use values of IC50 504.840 μg/mL, whereas IC50 values doxorubicin is 141.055 nM. The 
synergistic effect was shown a combination of methanol extract leaves marigolds and 
doxorubicin at concentrations of 84.17 μg/mL -23.5 nM; 84.17 μg/mL -47 nM; 126.25 μg/mL  
-23.5 nM; 252.5 μg/mL -35.25 nM and 252.5 μg/mL -71 nM with a combination index value 
(CI) consecutively of 0.5; 0.6; 0.6; 0.6 and 0.6. Observations modulation of cell cycle and 
apoptosis induction combination of methanol extract leaves marigolds and doxorubicin at 
concentrations of 84.17 μg/mL -23.5 nM, said that a combination of the methanol extract of 
leaves of marigolds and doxorubicin to inhibit the proliferation of cells in G2/M phase and 
able to induce apoptosis of breast cancer cells T47D. 
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INTRODUCTION 
 
Breast cancer is type of cancer that 
common suffered by women in the world. 15% 
of them end up with death. Currently Indonesia 
occupy the first position in Asia as a country 
with the highest number of new breast cancer 
cases, that is 25,208 cases (IARC, 2013). 
The main priority of breast cancer 
therapy was conducted using agent 
chemotherapy. One of the agents chemotherapy 
known as an effective cancer therapy is 
doxorubicin (Drummond, 2007). But the use of 
doxorubicin  in clinical restricted because of 
side effects cardiomyopathy and congestive 
heart failure that can cause death (Singal, et al., 
2001).  
To overcome the side effects of the 
doxorubicin, one strategy developed is by 
combining doxorubicin and natural material 
that has cytotoxic effect, one of it is kenikir 
leaves (Cosmos caudatus Kunth.), Fita, et al., 
2015 prove that the combination of methanol 
extract of marigolds leaves extract (MLE) and 
doxorubicin showed cytotoxic effect that strong 
synergistic. In this study, we observed the 
ability of a combination of MLE and 
doxorubicin in modulate cell cycle and improve 
induction of cell apoptosis on T47D breast 
cancer cells. The molecular search of the 
mechanism is going to be beneficial as the basic 
development of kenikir leaves as a 
cochemotherapy agnet that can be minimize the 
therapeutic dose of doxorubicin so that it will 
minimize the side effects of the use of 
doxorubicin, and also to convince the health 
practitioners to use natural material in the 
practice of treating breast cancer.  
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MATERIALS AND METHODS 
 
Study Period 
This research has been held in March 
2016 until July 2016, including observation, 
collection raw materials, making methanol 
extract of marigolds leaves in the laboratory 
phytochemical, Wahid Hasyim University. 
Cytotoxic assay dan observation of cell cycle 
modulation and apoptosis in the laboratory 
molecular biology BP2TOOT, Tawangmangu, 
and data analysis until the preparation of report. 
 
Material and Instruments 
Extraction materials : Marigold leaves 
(Cosmos caudatus Kunth.), methanol.  
Cytotoxic assay, cell cycle and apoptosis 
materials : methanol extract of marigold 
leaves, DMSO, doxorubicin, T47D breast 
cancer cell lines, DMEM media, grower media 
containing FBS 10% and penicillin-
streptomycin 1%, PBS, MTT reagent, Stopper 
reagent in the form of SDS 10% in HCL 0.01 
N, Flowcytometry reagent  (Propidium Iodide 
(PI), RNAse and 0.1% (v/v) Triton-X 100 in 
PBS, alcohol 70%, annexin V-FLOUS 
Apoptosis Detection Kit, Tripsin- EDTA 
0.25%. 
Extraction instruments: soxhletation 
instrumen, rotary evaporator, beakerglass, 
measuring glass, funnel,boiling stone, heater. 
Cytotoxic assay, cell cycle and apoptosis 
observation instruments: vortex, CO2 5% 
incubator, treated tissue culture dish diameter 
10 cm, inverted microscop, laminar air flow 
cabinet, micropipet, yellow-tip, blue-tip, 
reaction tube, conical tube, 96 well-plate, 6 
well-plate, sentrifuge tube, sentrifuge, object 
glass, flowcytometer, digital camera, ELISA 
reader. 
 
Plant Determination 
Plant determination was done in Ecology 
dan Biosystematic Laboratory, Biology 
Departement, Faculty of Mathematics and 
Sciences, Diponegoro University, Semarang.  
 
Extraction 
Marigold leaves washed with water and 
dried in an oven with the temperature maximum 
400
o
c until the water levels < 10 % (Depkes RI, 
1979). Simplisia mashed and sifted with B30 
sieve. Simplisia extracted with methanol used 
the soxhletation method.The obtained liquid 
extract  then volatilized with rotary evaporators 
to obtained the viscous consistency. 
 
Cytotoxic Assay 
Test Solution of MLE dissolved in 
DMSO and made the series a concentration of 
1000, 850, 700, 550, 400, 250, and 100 µg/mL, 
whereas doxorubicin made the series a 
concentration of 250, 200, 150, 100, 50, 25, 
12.5, and 2.5 nM, T47D cells in a nitrogen tank 
subcultured in a culture medium until ready to 
test. A number of 8x10
3
 cells/well distributed in 
wells on a 96 well plate and incubated in 5% 
CO2 incubator at 37°C for overnight. Step in 
single testing or in combination, namely the test 
solution was added to the wells and incubated 
for 24 hours. Media is removed, then each of 
the wells are washed with PBS, then added to 
the culture medium of 100 mL and 10 mL MTT 
with a concentration of 5 mg/mL. Cells were 
incubated for 2-4 hours to form formazan. MTT 
reaction was stopped by the stopper reagent in 
the form of 10% SDS in 0.01 N HCl and 
incubated overnight at room temperature in a 
dark place. Uptake is read by ELISA reader at a 
wavelength of 595 nm (Mossman, 1983). 
 
Observation of Cell Cycle using 
Flowcytometry 
A number of 5x10
5
 cells/well transferred 
into a 6-well plate and incubated in 5% CO
2
 
incubator at 37°C for 24 hours. Test solution is 
added to the wells and incubated for 24 hours. 
The cell media transferred to conical, 500 mL 
of PBS was added to the wells and transferred 
in the same conical. Cells were harvested by 
adding 200 mL of 0.25% trypsin-EDTA and 
incubated 3 minutes, added 1 mL of culture 
medium/well and resuspended. The harvested 
cells are transferred into the same conical and 
pitting rinsed with PBS and then transferred to 
the same conical. Centrifuged by 600 rpm for 5 
minutes and the supernatant was discarded. The 
precipitated cells were washed with cold PBS 
500 mL and centrifuged by 600 rpm for 5 
minutes and then PBS discarded, added 500 mL 
of 70% alcohol and stored conical at a 
temperature of 37
o
C for 30 minutes and then 
centrifuged by 600 rpm for 5 minutes and the 
alcohol is removed, add 500µL PBS and 
centrifuged by 2000 rpm for 3 minutes. 
Flowcytometry reagent is added and allowed to 
stand 30 minutes in conical wrapped in 
aluminum foil. The cell suspension is 
transferred to flowcyto-tube and analyzed by 
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FACS Calibur flowcytometer program to 
determine the profile of the cell cycle (Ayers, et 
al., 2011). 
 
Observation of Apoptosis using 
Flowcytometry 
A number of 5x10
5
 cells/well transferred 
into a 6-well plate, incubated in a 5% CO2 
incubator at 37°C for overnight. Test solution is 
added to the wells and incubated for 24 hours. 
Conical transferred to the cell media and the 
wells are washed with 500 mL of PBS, then 
transferred to the same conical and harvesting 
with the addition of 0.25% trypsin-EDTA as 
much as 150 mL/well and incubated 3 minutes. 
Media culture is added 1000 mL/well and cells 
resuspended. Cells centrifuged by 600 rpm for 
5 minutes, the media removed. The cell 
sediment was dissolved in buffer kit annexin V-
FLOUS. The cell suspension was homogenized 
and incubated for 15 min at room temperature 
in conical wrapped in aluminum foil. Cells are 
then transferred to flowcyto-tube and analyzed 
(Gattenlohner, et al., 2009). 
 
Analysis of Cytotoxicity Assay Data 
Data absorbance or OD (Optical 
Dencity) of ELISA reader is converted to 
percent of cell viability using the following 
formula: 
 
 
 
The results of calculations were analyzed 
using Microsoft Excel 2007 to obtain single 
treatment IC50 of MLE and doxorubicin. IC50 
obtained from a single treatment is used to 
determine the concentration of the MLE 
combination and doxorubicin. Potential 
cytotoxic doxorubicin MLE combination 
determined by calculating the Combination 
Index using the formula (Reynolds and Maurer, 
2005): 
 
CI = (D)1/(Dx)1 + (D)2/(Dx)2 
 
The concentration of each test compound 
is used to test the combination stated in D1 and 
D2, whereas the concentration of a single 
compound derived from the interpolated 
percent cell viability caused by combination 
treatment (X) in a single regression equation 
expressed in DX1 and DX2. 
 
Analysis of Cell Cycle Observation Data  
Data were analyzed by flowcytometry 
flowing program to see the distribution of the 
percentage of cells in G1 phase, S and G2/M. 
The inhibition of the cell cycle can be 
determined by comparing the treatment effect 
of the test solution with control cells. 
 
Analysis of Apoptosis Observation Data 
Flowcytometry data showed the 
percentage of cells contained in four quadrants, 
namely LL (lower left), LR (lower right), UL 
(upper left), and UR (upper right). LL quadrant 
showed the percentage of living cells, LR 
quadrant showed the percentage of cells 
undergoing early apoptosis, UL quadrant 
showed percent cell necrosis, UR quadrant 
showed the percentage of cells undergoing late 
apoptosis. Induction of apoptosis known to 
compare the effects of single compounds and 
combination treatment with control cells. 
 
RESULTS AND DISCUSSION  
 
The single cytotoxicity assay give the 
MLE IC50 values of 504.840 g/mL. It was less 
compared to research of Fita, et al., 2015 which 
provide IC50 of 778.05 µg/mL (Fita, et al., 
2015), whereas doxorubicin cytotoxicity give 
IC50 value of 141.055 nM. Cytotoxicity profile 
of MLE which shows its ability in lowering 
T47D cells viability is presented in Fig. 1, 
while the morphology of breast cancer cells 
after treatment with doxorubicin and MLE is 
shown in Fig. 2.  
Cytotoxicity combination assay was 
conducted to know the effectivy of the 
combination MLE and doxorubicin in 
inhibiting the growth of T47D cells. In the 
combination assay, the concentration of MLE 
and doxorubicin was lowered to under its IC50 
respectively so can suppress the side effects of 
doxorubicin. The results show the Combination 
Index of MLE and doxorubicin as shown in 
Table 1. 
Fauzia, et al., 2017 
Indones. J. Cancer Chemoprevent., 7(3), 79-86  
 
82 
 
 
Figure 1. The ability of MLE to decrease the viability T47D cell. Methanol extract kenikir leaves 
inhibits the growth of T47D breast cancer cell gives IC50 value of 504.840 µg/mL. 
 
 
 
           (A)  (B)         (C) 
 
Figure 2. The morphology of T47D cell after incubation for 24. Control of T47D cell (A); Doxorubicin 
250 nM (B); MLE 1000 μg/mL (C). The living cells is indicated by ( ) while the dead 
cells is marked by ( ) 
 
 
 
Table 1. Combination Index (CI) of MLE and Doxorubicin in T47D breast cancer cells. 
MLE 
Concentration 
(μg/mL) 
Doxorubicin concentration (nM) 
71 47.00 35.25 23.50 
252.50 0.6 1.0 0.6 0.7 
168.33 1.1 1.1 1.0 0.9 
126.25 1.4 0.8 1.3 0.6 
84.17 1.1 0.6 1.0 0.5 
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Combination Index in Table 1 shows 
that the combination MLE of 252.50 μg/mL 
with doxorubicin of 71 nM and 35.25 nM; the 
combination MLE of 126.25 μg/mL and 
doxorubicin of 23.50 nM; and the combination 
MLE of 84.17 μg/ml and doxorubicin of 47.00 
nM and 23.50 nM, provides a synergistic effect 
which means it has a greater cytotoxic effect 
than the sole effect of each compound. The best 
synergistic effect is shown by the combination 
MLE of 84.17 μg/mL and doxorubicin of 23.50 
nM with CI value of 0.5. Doxorubicin and MLE 
combination effects in T47D breast cancer cells 
is shown in Fig. 3. 
Flowcytometry analysis using FACS 
Calibur program is presented in Fig. 4, while 
the percentage of cell cycle distribution in 
Table 2. The result shows that the control cells 
undergo cell distribution in phase G1, S and 
G2/M. Single treatment of MLE causes an 
accumulation of cells in G2/M phase, while 
single treatment of Doxorubicin causes an 
accumulation of cells in G1 phase. The 
different mechanism of action may occur for a 
synergistic effect in combination MLE and 
Doxorubicin. Combination Index calculation 
results as shown in Table 1 and Fig. 3 
confirmed the synergism MLE and 
Doxorubicin. Doxorubicin and MLE 
combination treatment is lowering the number 
of cells that accumulate in the G1 phase which 
was originally raised by doxorubicin, while 
increasing accumulation of cells in G2/M 
phase. It shows the influence MLE in 
increasing cell accumulation in G2/M phase, 
which means giving an inhibitory effect on 
G2/M phase. 
The results of apoptosis induction is 
presented in Fig. 5, while the percentage of cell 
death are shown in Table 3. 
 
 
 
  
 
Figure 3. Combination effects of MLE and doxorubicin in T47D breast cancer cells. 
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(A)   (B)          (C)        (D) 
 
Figure 4. Analysis of T47D cell cycle distribution using flowcytometry. Cell control (A); MLE of 84.17 
μg/mL (B); Doxorubicin of 23.5 nM (C); MLE of 84.17 μg/mL + Doxorubicin of 23.5 nM (D). 
 
 
 
 
Table 2. The distribution of T47D cells in cell cycle phases after treatment 
Sample G1 phase (%) S phase (%) G2/M phase (%) 
Kontrol Sel 32.78 30.24 28.08 
MLE 84.17 μg/mL 35.24 21.74 44.29 
Doxorubicin 23.5 nM 46.57 16.45 39.10 
MLE 84.17 μg/mL + Doxorubicin 23.5 nM 30.37 26.76 50.20 
 
 
 
 
(A)   (B)           (C)       (D) 
 
Figure 5. Analysis of T47D cell cycle distribution using flowcytometry. Cell control (A); MLE of 84.17 
μg/mL (B); Doxorubicin of 23.5 nM (C); MLE of 84.17 μg/mL + Doxorubicin of 23.5 nM (D). 
 
 
 
 
 
Table 3. Death Percentage Cells after Treatment in Breast Cancer Cells T47D 
 
Cell 
control 
MLE 84.17 
μg/mL 
Doxorubicin 
23.5 nM 
MLE 84.17 μg/mL + 
Doxorubicin 23.5 nM  
Early apoptosis (%) 6.97 1.30 20.72 1.10 
Late apoptosis (%) 1.44 47.84 5.52 42.82 
Necrosis (%) 0.30 48.39 1.06 51.11 
Total (%) 8.71 97.53 27.30 95.03 
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As shown in Table 3, combination of 
MLE and doxorubicin provides apoptosis 
percentage of 43.92% which is presenced the 
induction of apoptosis in T47D breast cancer 
cells. Treatment of Doxorubicin sole give the 
apoptosis percentage of 26.24% indicates the 
lower induction of apoptosis than its 
combination, which means that the addition 
MLE is able to increase the apoptotic effects of 
doxorubicin. The mechanism of action of 
doxorubicin involves its bond with DNA 
through intercalation between the base pairs 
and inhibit the synthesis of DNA and RNA 
through rioting template and steric hindrance. 
Another mechanism of action involves binding 
to the lipid membrane of cells that will turn 
various cellular functions and interacts with 
topoisomerase II to form the complex of DNA 
cutter (Rock and DeMichele, 2003). MLE 
contains flavonoids and quercetin glycosides 
(Abas, et al., 2003). Quercetin is able to induce 
apoptosis through the mitochondrial pathway, 
which disrupt MMP thereby triggering the 
release of cytochrome c into the cytoplasm and 
the activation of caspase-3 and caspase-7 
(Gibellini, et al., 2011). 
 
CONCLUSION  
 
Based on observations of modulation of 
cell cycle and apoptosis induction, MLE and 
doxorubicin combination with a concentration 
of 84.17 ug/mL -23.5 Nm is able to inhibit cell 
proliferation in G2/M phase and increase the 
induction of apoptosis of breast cancer cells 
T47D. 
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